<DOC>
	<DOCNO>NCT00642915</DOCNO>
	<brief_summary>To estimate efficacy combination therapy Lantus plus Amaryl control blood glucose Japanese patient type 2 diabetes fail OAD therapy , document ability preserve endocrine pancreatic function Lantus plus Amaryl combination therapy</brief_summary>
	<brief_title>Insulin Glargine Benefits Japanese Pts Outside Japan ( US Brazil )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>All patient plan enrollment study noninsulindependent diabetes mellitus ( NIDDM ) ( type 2 diabetes ) able maintain good metabolic control OADs . Enrolled patient could male female , documented Japanese ethnic origin , age 20 70 year , inclusive .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>